000 | 01845 a2200493 4500 | ||
---|---|---|---|
005 | 20250517025135.0 | ||
264 | 0 | _c20160126 | |
008 | 201601s 0 0 eng d | ||
022 | _a1464-3391 | ||
024 | 7 |
_a10.1016/j.bmc.2015.03.035 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhen, Xiao-Li | |
245 | 0 | 0 |
_aSynthesis and biological evaluation of open-chain analogs of cyclic peptides as inhibitors of cellular Shp2 activity. _h[electronic resource] |
260 |
_bBioorganic & medicinal chemistry _cMay 2015 |
||
300 |
_a2562-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcetylcholinesterase _xchemistry |
650 | 0 | 4 | _aCatalytic Domain |
650 | 0 | 4 |
_aCathepsin B _xantagonists & inhibitors |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aEnzyme Assays |
650 | 0 | 4 |
_aEnzyme Inhibitors _xchemical synthesis |
650 | 0 | 4 |
_aGPI-Linked Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 | _aHeLa Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIMP Dehydrogenase _xantagonists & inhibitors |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 | _aMolecular Docking Simulation |
650 | 0 | 4 |
_aPeptides, Cyclic _xchemical synthesis |
650 | 0 | 4 |
_aProteasome Endopeptidase Complex _xdrug effects |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 |
_aProtein Tyrosine Phosphatase, Non-Receptor Type 11 _xantagonists & inhibitors |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aYin, Wen-Hui | |
700 | 1 | _aTian, Xia | |
700 | 1 | _aMa, Zhen-Jie | |
700 | 1 | _aFan, Shi-Ming | |
700 | 1 | _aHan, Jian-Rong | |
700 | 1 | _aLiu, Shouxin | |
773 | 0 |
_tBioorganic & medicinal chemistry _gvol. 23 _gno. 10 _gp. 2562-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmc.2015.03.035 _zAvailable from publisher's website |
999 |
_c24796132 _d24796132 |